LAMA2

laminin subunit alpha 2, the group of Laminin subunits

Basic information

Region (hg38): 6:128883138-129516566

Previous symbols: [ "LAMM" ]

Links

ENSG00000196569NCBI:3908OMIM:156225HGNC:6482Uniprot:P24043AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • congenital merosin-deficient muscular dystrophy 1A (Supportive), mode of inheritance: AR
  • congenital merosin-deficient muscular dystrophy 1A (Strong), mode of inheritance: AR
  • muscular dystrophy, limb-girdle, autosomal recessive 23 (Strong), mode of inheritance: AR
  • LAMA2-related muscular dystrophy (Definitive), mode of inheritance: AR
  • congenital merosin-deficient muscular dystrophy 1A (Definitive), mode of inheritance: AR
  • congenital merosin-deficient muscular dystrophy 1A (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Schizophrenia; Muscular dystrophy, congenital merosin-deficient, 1A; Muscular dystrophy, limb-girdle, autosomal recessive 23AD/ARGeneralIn Muscular dystrophy, congenital merosin-deficient, 1A, Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing; In Schizophrenia, the evidence or clinical applicability is unclearMusculoskeletal; Neurologic7550355; 8887959; 8729391; 12552556; 16216942; 18700894; 20627570; 21953594; 22166137; 22675738; 23042115; 24611677; 25663498; 30055037
Clinically significant cardiomyopathy has not been described

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the LAMA2 gene.

  • LAMA2-related muscular dystrophy (307 variants)
  • Merosin deficient congenital muscular dystrophy (78 variants)
  • not provided (71 variants)
  • Muscular dystrophy, limb-girdle, autosomal recessive 23 (10 variants)
  • Inborn genetic diseases (8 variants)
  • Abnormality of the musculature (5 variants)
  • Merosin deficient congenital muscular dystrophy;Muscular dystrophy, limb-girdle, autosomal recessive 23 (4 variants)
  • Muscular dystrophy, limb-girdle, autosomal recessive 23;Merosin deficient congenital muscular dystrophy (3 variants)
  • Congenital muscular dystrophy due to partial LAMA2 deficiency (3 variants)
  • LAMA2-related disorder (2 variants)
  • Congenital Muscular Dystrophy, LAMA2-related (2 variants)
  • Qualitative or quantitative defects of merosin (1 variants)
  • Muscular dystrophy, congenital, merosin deficient or partially deficient (1 variants)
  • Hypotonia (1 variants)
  • Myalgia;Exercise-induced myalgia;Elevated circulating creatine kinase concentration (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the LAMA2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
6
clinvar
1202
clinvar
16
clinvar
1225
missense
4
clinvar
12
clinvar
1157
clinvar
85
clinvar
10
clinvar
1268
nonsense
125
clinvar
147
clinvar
2
clinvar
274
start loss
1
clinvar
1
frameshift
185
clinvar
153
clinvar
338
inframe indel
2
clinvar
31
clinvar
1
clinvar
34
splice donor/acceptor (+/-2bp)
44
clinvar
141
clinvar
2
clinvar
1
clinvar
188
splice region
2
2
84
230
9
327
non coding
1
clinvar
14
clinvar
715
clinvar
152
clinvar
882
Total 360 456 1212 2004 178

Highest pathogenic variant AF is 0.0000592

Variants in LAMA2

This is a list of pathogenic ClinVar variants found in the LAMA2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
6-128883143-C-T Congenital muscular dystrophy due to partial LAMA2 deficiency Uncertain significance (Jan 13, 2018)355233
6-128883147-A-G Congenital muscular dystrophy due to partial LAMA2 deficiency Likely benign (Jan 13, 2018)355234
6-128883150-AGCT-A Congenital Muscular Dystrophy, LAMA2-related Uncertain significance (Jun 14, 2016)355235
6-128883174-G-A Congenital muscular dystrophy due to partial LAMA2 deficiency Benign (Jul 27, 2018)355236
6-128883227-TC-T not specified Likely benign (Aug 10, 2017)421527
6-128883243-A-G not specified Uncertain significance (Jun 19, 2018)1336740
6-128883247-T-C LAMA2-related muscular dystrophy • Merosin deficient congenital muscular dystrophy Pathogenic/Likely pathogenic (Jun 23, 2023)477459
6-128883250-C-G LAMA2-related muscular dystrophy Uncertain significance (Dec 03, 2021)999376
6-128883251-G-A LAMA2-related muscular dystrophy Likely benign (Oct 29, 2023)1991208
6-128883251-G-T LAMA2-related muscular dystrophy Likely benign (Jul 10, 2022)2015706
6-128883252-G-A LAMA2-related muscular dystrophy Uncertain significance (Apr 12, 2022)2189738
6-128883255-GC-G LAMA2-related muscular dystrophy Pathogenic/Likely pathogenic (Feb 04, 2022)524103
6-128883257-C-G LAMA2-related muscular dystrophy Likely benign (Apr 14, 2022)1099739
6-128883257-C-T LAMA2-related muscular dystrophy Likely benign (Sep 14, 2023)2913817
6-128883257-CGCCGGGGTCCTCCTCCTTCTGCTGCTCTCCGGAG-C Merosin deficient congenital muscular dystrophy Likely pathogenic (Nov 19, 2022)2676267
6-128883258-G-A LAMA2-related muscular dystrophy Conflicting classifications of pathogenicity (Jan 21, 2024)193095
6-128883258-G-T LAMA2-related muscular dystrophy Conflicting classifications of pathogenicity (Sep 28, 2023)870965
6-128883260-C-A LAMA2-related muscular dystrophy Likely benign (Dec 02, 2023)750248
6-128883260-C-T LAMA2-related muscular dystrophy Likely benign (Jan 09, 2024)2062017
6-128883263-G-A LAMA2-related muscular dystrophy Likely benign (Sep 21, 2023)1156786
6-128883263-G-C LAMA2-related muscular dystrophy Likely benign (Nov 07, 2023)1579384
6-128883263-G-T LAMA2-related muscular dystrophy Likely benign (Oct 31, 2022)1630575
6-128883264-G-GTCC Merosin deficient congenital muscular dystrophy Uncertain significance (Apr 16, 2018)557889
6-128883269-C-A LAMA2-related muscular dystrophy Likely benign (Mar 24, 2021)1641688
6-128883269-C-T LAMA2-related muscular dystrophy Likely benign (Jan 13, 2024)1981740

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
LAMA2protein_codingprotein_codingENST00000421865 65633373
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.41e-471.0012533104171257480.00166
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.030016981.69e+31.000.000094820542
Missense in Polyphen670726.430.922328975
Synonymous-1.446666201.070.00003635955
Loss of Function4.501021640.6210.000009481988

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.002530.00253
Ashkenazi Jewish0.001690.00169
East Asian0.004030.00403
Finnish0.0005080.000508
European (Non-Finnish)0.001690.00167
Middle Eastern0.004030.00403
South Asian0.001640.00163
Other0.001630.00163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components.;
Disease
DISEASE: Merosin-deficient congenital muscular dystrophy 1A (MDC1A) [MIM:607855]: Characterized by difficulty walking, hypotonia, proximal weakness, hyporeflexia, and white matter hypodensity on MRI. {ECO:0000269|PubMed:11591858, ECO:0000269|PubMed:12552556, ECO:0000269|PubMed:27234031}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
PI3K-Akt signaling pathway - Homo sapiens (human);ECM-receptor interaction - Homo sapiens (human);Focal adhesion - Homo sapiens (human);Dilated cardiomyopathy (DCM) - Homo sapiens (human);Viral myocarditis - Homo sapiens (human);Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human);Small cell lung cancer - Homo sapiens (human);Amoebiasis - Homo sapiens (human);Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human);Toxoplasmosis - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Arrhythmogenic Right Ventricular Cardiomyopathy;Alpha 6 Beta 4 signaling pathway;Focal Adhesion;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;PI3K-Akt Signaling Pathway;Signal Transduction;prion pathway;Alpha6Beta4Integrin;Laminin interactions;Extracellular matrix organization;agrin in postsynaptic differentiation;a6b1 and a6b4 Integrin signaling;Non-integrin membrane-ECM interactions;ECM proteoglycans;MET activates PTK2 signaling;MET promotes cell motility;Signaling by MET;Signaling by Receptor Tyrosine Kinases;Beta1 integrin cell surface interactions;Alpha6 beta4 integrin-ligand interactions (Consensus)

Recessive Scores

pRec
0.636

Intolerance Scores

loftool
0.948
rvis_EVS
0.5
rvis_percentile_EVS
79.64

Haploinsufficiency Scores

pHI
0.300
hipred
Y
hipred_score
0.680
ghis
0.517

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.513

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Lama2
Phenotype
hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; endocrine/exocrine gland phenotype; muscle phenotype; craniofacial phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype;

Zebrafish Information Network

Gene name
lama2
Affected structure
fast muscle cell
Phenotype tag
abnormal
Phenotype quality
detached from

Gene ontology

Biological process
cell adhesion;axon guidance;muscle organ development;Schwann cell differentiation;regulation of cell adhesion;extracellular matrix organization;regulation of cell migration;positive regulation of synaptic transmission, cholinergic;regulation of embryonic development
Cellular component
extracellular region;basement membrane;neuromuscular junction;sarcolemma;synaptic cleft;dendritic spine;collagen-containing extracellular matrix
Molecular function
signaling receptor binding;structural molecule activity;extracellular matrix structural constituent